☰

Adaptyv Bio Inc.

A high-throughput protein design foundry

A US foundry running automated binding assays that cut protein experiment costs, serving computational protein designers

Industry
Protein Engineering
Headquarters
USA
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Adaptyv Bio Inc.'s published strategy and is not endorsed by, or produced in cooperation with, Adaptyv Bio Inc.. Company website

Strategic priorities

Adaptyv Bio is a US protein design foundry that solves the critical data bottleneck in protein engineering — traditional protein engineering suffers from 10-week turnaround and costs exceeding USD 1,000 per experimental execution, preventing the rapid iteration that AI models require for training. Adaptyv's automated high-throughput binding assays and kinetics measurements address this bottleneck by reducing reagent consumption by 1,000x while increasing experimental throughput, enabling protein designers to iterate on their computational predictions faster.

The company's strategic position is as infrastructure for computational protein designers — providing wet-lab execution at a scale and cost that makes AI-driven protein design economically viable. The Proteinbase platform serves as a centralised hub for experimental protein design data, fostering open-source benchmarking through competitions like the EGFR binder challenge. The company is expanding globally and doubling team size while maintaining consistency across distributed workcells.

The core digital challenge is the integration of diverse analytical instruments — BLI, mass spectrometry, chromatography — into a unified control loop, while managing third-party opaque devices not designed for external automated control. The company also faces the dual requirement of maintaining research flexibility for early customers while building the GxP-compliant infrastructure required for pharmaceutical applications.

Challenges we see

  • Operations Manufacturing

    Experimental execution bottleneck blocking AI model improvement

    Traditional protein engineering costs USD 1,000+ per experimental execution with 10-week turnaround — creating a bottleneck that prevents the rapid design-test-learn cycles that AI models require for training. Every month of waiting for experimental results is a month when the AI model is not improving.

    When the experimental validation of AI-generated protein designs takes 10 weeks, the computational protein designer's competitive position is determined by how fast they can iterate — the foundry that reduces this bottleneck captures the protein design market.

  • Digital Integration

    Disconnected analytical instrument ecosystem

    Adaptyv's workcells integrate diverse analytical instruments — BLI, mass spectrometry, chromatography — that were not designed for external automated control. The third-party opaque device problem means each new instrument integration requires custom engineering, and the data from each instrument is in a different format.

    When each new assay type requires a custom integration project, the foundry's ability to rapidly add capabilities is constrained by engineering bandwidth rather than by the underlying technology — the modular expansion that customers require is slowed by the integration work that precedes each new capability.

  • Digital Integration

    Vendor lock-in limiting best-of-breed flexibility

    The industry suffers from proprietary hardware and software ecosystems that prevent integration of best-of-breed technologies — lock-in to a single vendor's instrument stack limits the assay types that can be offered and increases maintenance costs as the vendor relationship becomes more critical.

    When Adaptyv is locked into a single vendor's instrument ecosystem, the company cannot offer the best assay for each protein design challenge — the customer value proposition is weakened by the limitation that the proprietary ecosystem imposes.

  • Operations Operations

    Scaling infrastructure for global workcell deployment

    As Adaptyv doubles team size and expands globally, maintaining consistency across distributed workcells while ensuring rapid deployment of new capabilities becomes increasingly challenging — the operational complexity of distributed workcells grows faster than the team's ability to manage it manually.

    When a new assay capability is developed at one workcell, replicating it at other geographic nodes requires manual deployment effort that does not scale — the distributed expansion that customers require is slowed by the deployment complexity.

  • Compliance Regulatory

    GxP compliance for pharmaceutical customer segment

    As Adaptyv expands into GxP-compliant pharmaceutical applications, ensuring automated workcells meet FDA and GMP requirements while maintaining research flexibility becomes increasingly complex — the same workcell must serve both early-access research customers and validated pharmaceutical production customers.

    When pharmaceutical customers require GxP-compliant execution for their protein designs, the workcell infrastructure must support both validated and non-validated operating modes simultaneously — the operational complexity of maintaining two modes on the same equipment increases the risk of compliance failures.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Automated foundry integration platform for high-throughput protein execution

    High-throughput protein execution at USD 1,000 per experiment is economically unviable for AI model training that requires thousands of experimental validations. The bottleneck prevents computational protein designers from iterating at the speed their models require.

    Deploy an automated foundry integration platform that connects Adaptyv's diverse analytical instruments into a unified data and control ecosystem — reducing cycle times to days while processing thousands of proteins daily, establishing the Foundry-as-a-Service model at the scale that computational protein designers require.

    • Adaptyv Bio current throughput and cost per experiment analysis
    • Protein design foundry market requirements assessment

  2. MTP-based modular workcell orchestration for assay flexibility

    Integrating diverse analytical instruments — BLI, mass spectrometry, chromatography — into a unified control loop requires complex orchestration logic while managing opaque third-party devices not designed for external automated control. Each new assay type requires a custom integration project.

    Implement MTP-based modular workcell orchestration that enables plug-and-produce assay integration — new analytical instruments are added to the workcell without rewriting code, and the assay library expands to serve more protein design challenges without proportional engineering investment.

    • Adaptyv Bio analytical instrument inventory and integration complexity assessment
    • Current workcell orchestration approach and MTP standard feasibility

  3. Protein engineering digital twin for virtual experiment optimisation

    Developing new protein designs requires extensive wet-lab experimental cycles with high costs for failed experiments. The experimental bottleneck prevents the full exploitation of computational protein design capabilities that could otherwise reduce the experimental cost per successful design.

    Build a digital twin simulation platform for protein engineering processes — enabling virtual optimisation of experimental conditions before expensive wet-lab execution, reducing the experimental cycles required per successful protein design.

    • Adaptyv Bio experimental cycle cost analysis and failure rate assessment
    • Current experimental planning approach and digital twin feasibility

  4. Real-time process intelligence and KPI dashboards for workcell operations

    Scientists lack real-time visibility into process conditions — relying on post-experiment analysis via Excel reports prevents proactive intervention and optimal process control during the experimental run itself.

    Deploy advanced visualisation dashboards with calculated biological KPIs, Golden Batch overlays, and predictive analytics — transforming retrospective analysis into proactive process control and enabling scientists to monitor and optimise protein engineering processes in real time.

    • Adaptyv Bio current process monitoring and data review workflow assessment
    • Real-time process intelligence technology options for protein engineering

  5. Enterprise-grade containerised cloud infrastructure for global scaling

    As Adaptyv doubles team size and expands globally, the operational complexity of distributed workcells grows faster than the team's ability to manage it manually. Manual deployment of new capabilities at new geographic nodes creates inconsistency and delays.

    Establish containerised, high-availability cluster architecture with Infrastructure as Coe templates — enabling rapid global deployment and continuous workload migration between nodes while maintaining the operational consistency that pharmaceutical customer segments require.

    • Adaptyv Bio global expansion plan and distributed operations assessment
    • Current infrastructure deployment approach and IaC feasibility

What we'd propose

  • Digital Lab

    Automated Foundry Integration Platform

    We build an automated foundry integration platform connecting Adaptyv's diverse analytical instruments — BLI, mass spectrometry, chromatography — into a unified data and control ecosystem with design-to-lab API workflows and automated data pipelines — reducing protein experimental cycle times to days while processing thousands of proteins daily.

    • Design-to-lab API for automated experiment execution

      Computational protein designs submitted directly to the workcell

      Build the design-to-lab API that connects computational protein design tools directly to the workcell execution platform — computational designs are submitted, queued, and executed without manual intervention, reducing the turnaround from prediction to experimental validation.

    • Automated data pipelines from all analytical instruments

      BLI, mass spec, and chromatography data flowing automatically

      Deploy automated data ingestion pipelines from BLI, mass spectrometry, and chromatography instruments — every experimental result is captured, normalised, and loaded into Proteinbase automatically at the point of generation.

    • Cross-instrument data normalisation and quality scoring

      All assay data in a unified format with quality scores

      Configure cross-instrument data normalisation that puts all assay results — regardless of which instrument generated them — into a unified format with quality scores that enable comparison across assay types.

    • The experimental turnaround time drops from 10 weeks to days because the bottleneck of manual experiment preparation and data collection is eliminated — computational protein designers can iterate at the speed their AI models require.
    • The cost per experiment decreases because automated pipelines reduce the labour overhead of each experimental cycle — the 1,000x cost reduction target is achieved through automation rather than through reagent price negotiation.
    • The data quality improves because automated pipelines eliminate the transcription errors that manual data handling introduces — the Proteinbase platform receives clean, attributable data that is suitable for ML model training.

    We've done this before

    See how we do Digital Lab
  • Digital Lab

    MTP-Based Modular Workcell Orchestration

    We implement MTP-based modular workcell orchestration for Adaptyv's automated workcells — enabling plug-and-produce assay integration where new analytical instruments and assay types can be added without rewriting control code, allowing the assay library to expand in pace with customer demand.

    • MTP equipment modules for all instrument types

      BLI, mass spec, and chromatography defined as MTP-compliant modules

      Define MTP-compliant equipment modules for all analytical instruments — BLI, mass spectrometry, chromatography, liquid handling — each module handles the vendor-specific control interface and exposes a standardised assay control interface to the orchestration layer.

    • Plug-and-produce assay onboarding workflow

      New assay types onboarded in hours, not weeks

      Build the plug-and-produce onboarding workflow — when a new assay type is required by a customer, the MTP module is loaded and the assay is operational within hours rather than requiring the custom engineering project that currently precedes each new capability.

    • Assay library management and version control

      All assay protocols version-controlled and auditable

      Configure assay library management with version control for all assay protocols — each protein design experiment is executed against a specific version of the assay protocol, with full traceability to the protocol version used.

    • The assay library expands in pace with customer demand because new assay types are onboarded through module configuration rather than custom engineering — Adaptyv can serve more protein design challenges without proportional growth in engineering capacity.
    • Vendor lock-in is eliminated because the MTP standard provides a vendor-agnostic integration layer — Adaptyv can select the best instrument for each assay without being constrained by proprietary integration requirements.
    • The workcell can operate with mixed vendor instrument configurations — the flexibility to optimise the instrument mix for each assay type improves the quality and throughput of the experimental results.

    We've done this before

    See how we do Digital Lab
  • Enterprise AI

    Protein Engineering Digital Twin Platform

    We build a digital twin simulation platform for Adaptyv's protein engineering processes — cloud-agnostic simulation of experimental conditions that enables virtual optimisation of assay parameters before expensive wet-lab execution, reducing failed experiments and accelerating the design iteration cycle.

    • Experimental condition simulation for protein binding assays

      Binding assay outcomes predicted in simulation before execution

      Build simulation models for the key binding assay conditions — buffer composition, temperature, protein concentration — that predict experimental outcomes before the physical assay is run, enabling the pre-screening of conditions that are most likely to succeed.

    • Virtual experiment optimisation and design-of-experiments

      Optimal experimental conditions identified computationally

      Configure design-of-experiments optimisation that identifies the minimum set of physical experiments required to characterise a protein design's binding behaviour — reducing the experimental burden per protein design while maintaining the data quality required for model training.

    • Digital twin validation against physical experimental data

      Simulation accuracy verified and continuously improved

      Build the model validation pipeline that compares digital twin predictions against actual experimental results — continuously recalibrating the simulation models as more physical data accumulates and improving the accuracy of virtual experiment predictions.

    • The number of physical experiments required per successful protein design decreases because the simulation platform identifies promising conditions before wet-lab execution — the cost per successful design is reduced and the experimental throughput is multiplied.
    • The AI model training dataset quality improves because the simulation platform can generate synthetic training data for conditions that are too expensive or time-consuming to test physically — the model's accuracy improves without proportional increase in physical experimental cost.
    • The digital twin platform differentiates Adaptyv from commodity protein foundries — the simulation capability that customers cannot replicate at their own institutions is a compelling reason to use Adaptyv's platform over lower-cost alternatives.

    We've done this before

    See how we do Enterprise AI
  • Digital Lab

    Real-Time Process Intelligence System

    We deploy advanced visualisation dashboards and real-time KPI platforms for Adaptyv's workcell operations — calculated biological KPIs, Golden Batch overlays, and predictive analytics that transform retrospective experimental analysis into proactive process control, enabling scientists to monitor and optimise protein engineering in real time.

    • Live workcell KPI dashboard

      Every active experiment visible in real time

      Deploy live KPI dashboards that display the status of every active experiment across all workcells — protein concentration, binding kinetics, assay progress — giving the scientific team immediate visibility into the workcell operations without waiting for post-run reports.

    • Golden Batch comparison for binding assays

      Current experiment compared to the best historical performance

      Configure Golden Batch comparison overlays for the key binding assay types — every in-progress experiment is scored against the best historical performance, alerting scientists when an experiment is trending toward a suboptimal outcome.

    • Predictive experiment outcome analytics

      Experiment success probability estimated before results arrive

      Build predictive analytics that estimate the probability of experimental success based on early kinetic data — scientists can prioritise their attention on experiments that are trending toward positive results while considering whether to terminate experiments that are trending toward failure.

    • Scientists identify and address experiment deviations during execution rather than after the results arrive — the feedback loop between experimental execution and process optimisation is closed in real time.
    • The Golden Batch reference profile encodes institutional knowledge about what good experimental conditions look like — this knowledge is preserved and made accessible across the team as the platform accumulates more historical data.
    • The predictive outcome analytics improves the effective throughput of the workcell — scientists can reallocate experimental resources from experiments that are likely to fail toward experiments that are likely to succeed.

    We've done this before

    See how we do Digital Lab
  • Enterprise AI

    Enterprise-Grade Containerised Cloud Infrastructure

    We establish enterprise-grade, high-availability containerised cloud infrastructure for Adaptyv's global workcell network — Infrastructure as Code templates enabling rapid deployment at new geographic nodes, workload migration between nodes, and the operational consistency that pharmaceutical customer segments require.

    • Containerised workcell control plane

      Workcell control software deployed as containerised workloads

      Deploy containerised workcell control software that can be deployed consistently at any geographic node — the same control plane configuration that runs at the primary facility runs identically at any new node, ensuring operational consistency across the global workcell network.

    • Infrastructure as Code deployment templates

      New workcell nodes deployed from templates in hours

      Build Infrastructure as Code templates that define the complete workcell node configuration — network, compute, storage, instrument integration — enabling a new geographic node to be deployed from the template in hours rather than the weeks of manual deployment effort.

    • Cross-node workload migration and disaster recovery

      Workloads can migrate between nodes for resilience and capacity

      Configure cross-node workload migration that enables experimental workloads to move between geographic nodes — providing disaster recovery capability and the ability to route work to the node with available capacity during peak demand periods.

    • New geographic nodes are deployed faster because the IaC templates eliminate manual deployment work — the global expansion plan is not delayed by the engineering effort that manual deployment requires.
    • The operational consistency across distributed workcells improves because every node runs the same containerised configuration — pharmaceutical customers receive the same validated execution regardless of which geographic node processes their designs.
    • The disaster recovery capability protects against site-level disruptions — experimental work is resumable at an alternate node if the primary node experiences an outage, protecting customer commitments.

    We've done this before

    See how we do Enterprise AI

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Adaptyv Bio Inc.'s own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration 65 → 90
Diverse analytical instruments — BLI, mass spectrometry, chromatography — are not integrated into a unified data platform. The automated foundry integration platform connecting design tools to workcell execution and assay results to Proteinbase has not been fully built.
Process Automation 70 → 95
The workcell orchestration requires custom engineering for each new assay type. MTP-based modular orchestration has not been implemented. The assay library expansion is constrained by integration engineering bandwidth.
Predictive Analytics 50 → 85
Protein engineering digital twin simulation for virtual experiment optimisation has not been built. Scientists rely on retrospective experimental analysis rather than predictive simulation. The design-of-experiments optimisation capability is not yet operational.
Scalability Architecture 55 → 90
Global workcell expansion requires manual deployment effort at each new geographic node. Infrastructure as Code templates for rapid node deployment have not been built. The operational complexity of distributed workcells is growing faster than the team's ability to manage it.
Security Maturity 45 → 80
Cloud-connected workcells expose the laboratory to lateral movement cyber threats. IEC 62443 and NIS2 compliance requirements have not been formally assessed or implemented. The Zero Trust architecture for distributed workcells has not been designed.
Ecosystem Interoperability 60 → 90
Vendor lock-in to proprietary instrument ecosystems limits best-of-breed flexibility. MTP standard modules for analytical instruments have not been defined. The assay library expansion is constrained by the integration architecture.

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Adaptyv Bio Inc., and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].